Skip to main content
Equibles

AMERICAN CENTURY COMPANIES INC

Position in DSGN — Design Therapeutics, Inc.

CIK 748054 KANSAS CITY, MO
Back to DSGN Full portfolio

Position in DSGN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,111,657
+$413,269 QoQ
Shares Held
76,825
+17.0% QoQ
Ownership
0.123%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 136 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DSGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AMERICAN CENTURY COMPANIES INC holds $3,618,743,392 across 179 Biotechnology names. DSGN ranks #85 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 1,853,956 $558,096,374
2 ASND
Ascendis Pharma A/S
 1,400,575 $373,561,364
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 580,901 $288,550,953
4 ARGX
Argenx SE
 173,193 $160,683,269
5 IONS
Ionis Pharmaceuticals Inc
 1,947,076 $154,383,656
6 EXEL
Exelixis, Inc.
 1,791,664 $97,484,438
7 HRMY
Harmony Biosciences Holdings, Inc.
 2,539,512 $92,463,631
8 GPCR
Structure Therapeutics Inc.
 1,682,179 $90,282,546

All Filings in DSGN

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,111,657 76,825
2026-03-31 $698,388 65,638
2025-12-31 $542,145 57,798
2025-09-30 $382,915 50,852
2025-06-30 $156,317 46,385
2025-03-31 $171,441 44,415
2024-12-31 $241,339 39,115
2024-09-30 $175,570 32,634
2024-06-30 $71,465 21,333